Business Context and Reporting Period
This Form 8-K Current Report was filed by Novavax, Inc. on May 20, 2024. The filing discloses a material corporate event regarding the departure of a senior executive officer.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and employment terms.
Material Changes
The primary material change reported is the retirement of Filip Dubovsky, President of Research and Development, effective June 30, 2024. In connection with his retirement, the following arrangements have been established:
- Consulting Role: Dr. Dubovsky will provide consulting services for a 12-month period following his retirement.
- Compensation: A monthly consulting fee of $15,000.
- Benefits: The Company will pay COBRA premiums for up to 11 months, subject to election and eligibility.
- Equity: Existing equity awards will continue to vest based on service during the consulting period. Unexercised stock options will remain exercisable for 90 days after the consulting period ends.
- Termination: Either party may terminate the agreement with 30 days' prior written notice.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business strategy. The only risk or contingency noted is the potential early termination of the consulting agreement by either party. The full text of the Consulting Agreement will be filed as an exhibit to the Company's Form 10-Q for the quarter ended June 30, 2024.
Investor Verification Checklist
- Verify the exact effective date of Dr. Dubovsky's retirement (June 30, 2024).
- Confirm the total potential cost of the consulting arrangement ($180,000 in fees plus COBRA premiums).
- Review the upcoming Form 10-Q for the full text of the Consulting Agreement and details on equity vesting schedules.
- Monitor for announcements regarding the appointment of a successor to the President, Research and Development role.